Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? – A Case Report
Chiara Jeiziner,1 Samuel S Allemann,1 Kurt E Hersberger,1 Henriette E Meyer zu Schwabedissen2 1Pharmaceutical Care Research Group, Department Pharmaceutical Sciences, University of Basel, Basel, Switzerland; 2Biopharmacy, Department Pharmaceutical Sciences, University of Basel, Basel, SwitzerlandCor...
Saved in:
Main Authors: | Jeiziner C (Author), Allemann SS (Author), Hersberger KE (Author), Meyer zu Schwabedissen HE (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study
by: Bollinger A, et al.
Published: (2023) -
Enriching Medication Review with a Pharmacogenetic Profile – A Case of Tamoxifen Adverse Drug Reactions
by: Jeiziner C, et al.
Published: (2021) -
Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Switzerland: A Descriptive Study Using the Helsana Database
by: Wittwer NL, et al.
Published: (2022) -
Pharmacogenetics in Pharmaceutical Care-Piloting an Application-Oriented Blended Learning Concept
by: Céline K. Stäuble, et al.
Published: (2021) -
Pharmacogenetic Sex-Specific Effects of Methotrexate Response in Patients with Rheumatoid Arthritis
by: Francisco C. Ceballos, et al.
Published: (2023)